<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04497714</url>
  </required_header>
  <id_info>
    <org_study_id>ç ”2020-539</org_study_id>
    <nct_id>NCT04497714</nct_id>
  </id_info>
  <brief_title>Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study</brief_title>
  <official_title>Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The observed indexes of the four cervical lymph node diseases were identified by informatics&#xD;
      methods, and the differences in the diagnosis of the four diseases were evaluated, so as to&#xD;
      improve the clinical diagnosis rate and provide a research basis for the ultrasonic&#xD;
      evaluation of the surgical indications of cervical lymph node diseases in the future.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cervical lymph nodes tuberculosis</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>It was identified as cervical lymph node tuberculosis by imaging observation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervical lymphoma</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>It was identified as cervical lymphoma by imaging observation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervical lymph node metastasis</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>It was identified as Cervical lymph node metastasis by imaging observation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervical Reactive hyperplasia</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>It was identified as Cervical Reactive hyperplasia by imaging observation</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">500</enrollment>
  <condition>Lymph Node Disease</condition>
  <condition>Ultrasound Therapy; Complications</condition>
  <arm_group>
    <arm_group_label>Cervical lymph nodes tuberculosis</arm_group_label>
    <description>The patients with Cervical lymph nodes tuberculosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical lymphoma</arm_group_label>
    <description>The patients with</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical lymph node metastasis</arm_group_label>
    <description>The patients with</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical Reactive hyperplasia</arm_group_label>
    <description>The patients with</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasonic image collection</intervention_name>
    <description>Ultrasonic image collection,consist of three static images and one dynamic image</description>
    <arm_group_label>Cervical Reactive hyperplasia</arm_group_label>
    <arm_group_label>Cervical lymph node metastasis</arm_group_label>
    <arm_group_label>Cervical lymph nodes tuberculosis</arm_group_label>
    <arm_group_label>Cervical lymphoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with one of these four diseases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with one of these four diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Patients with severe heart and brain diseases and poor coagulation function. 2.&#xD;
             Undiagnosed patients are not included in the statistical analysis. 3. Image distortion&#xD;
             of CEUS acquisition cannot be analyzed.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>0571</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 27, 2020</study_first_submitted>
  <study_first_submitted_qc>August 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>August 2, 2020</last_update_submitted>
  <last_update_submitted_qc>August 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>individual participant data(IPD) can be shared after the main unit publish articles</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>by request</ipd_time_frame>
    <ipd_access_criteria>by request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

